Are mutations in K-RAS, BRAF and PIK3CA genes critical for response to adjuvant trastuzumab treatment in patients with HER-2 positive breast cancer?

Anne Marie Bak Jylling; Anders Aamann Rasmussen; Erik Hugger Jakobsen; René dePont Christensen; Flemming Brandt Sørensen

Are mutations in K-RAS, BRAF and PIK3CA genes critical for response to adjuvant trastuzumab treatment in patients with HER-2 positive breast cancer?

Anne Marie Bak Jylling, Anders Aamann Rasmussen, Erik Hugger Jakobsen, René dePont Christensen, Flemming Brandt Sørensen

Vejle Sygehus

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Originalsprog	Dansk
Artikelnummer	3
Tidsskrift	Journal of Cancer Therapeutics & Research
Vol/bind	3
Udgave nummer	3
ISSN	2049-7962
Status	Udgivet - 2014

Citationsformater

@article{8081663cb670465282a93e744e14efdd,

title = "Are mutations in K-RAS, BRAF and PIK3CA genes critical for response to adjuvant trastuzumab treatment in patients with HER-2 positive breast cancer?",

author = "{Bak Jylling}, {Anne Marie} and Rasmussen, {Anders Aamann} and Jakobsen, {Erik Hugger} and Christensen, {Ren{\'e} dePont} and S{\o}rensen, {Flemming Brandt}",

year = "2014",

language = "Dansk",

volume = "3",

journal = "Journal of Cancer Therapeutics & Research",

issn = "2049-7962",

publisher = "Herbert Publications Ltd",

number = "3",